Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) 2 issued the announcement on the progress of repurchasing the company's shares. As of February 28, 2022, the company has repurchased 7790608 shares, accounting for 0.5222% of the company's total share capital. The highest transaction price is 21.055 yuan / share, the lowest price is 16.01 yuan / share, and the total transaction amount is 14999616706 yuan (excluding stamp duty, transaction commission and other related expenses).
It is reported that Zhe Jiang Hua Hai Pharmaceuticalco.Ltd(600521) respectively held the second meeting of the seventh board of directors and the 2020 annual general meeting of shareholders on April 23, 2021 and May 18, 2021. The meeting deliberated and adopted the proposal on repurchase of shares of the company by means of centralized bidding transaction, It is agreed that the company will use its own funds to repurchase the company's shares in the form of centralized bidding transaction for the implementation of employee stock ownership plan or equity incentive, and the repurchase amount shall not be less than RMB 100 million (inclusive) and not more than RMB 200 million (inclusive), The repurchase price does not exceed 24.80 yuan / share (including) (the company originally set the upper limit of the repurchase price at 25 yuan / share. Because the company implemented the 2020 annual profit distribution plan, that is, the company distributed a cash dividend of 0.2 yuan per share (including tax), the company adjusted the upper limit of the repurchase price from 25 yuan / share to 24.80 yuan / share according to the provisions of relevant laws and regulations), The repurchase period is 12 months from the date when the company's 2020 annual general meeting deliberates and approves the share repurchase plan.
